+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Carglumic Acid"

From
Carglumic Acid - Global Strategic Business Report - Product Thumbnail Image

Carglumic Acid - Global Strategic Business Report

  • Report
  • May 2024
  • 192 Pages
  • Global
From
From
From
Global and Chinese Carglumic Acid Industry, 2021 Market Research Report - Product Thumbnail Image

Global and Chinese Carglumic Acid Industry, 2021 Market Research Report

  • Report
  • January 2021
  • 149 Pages
  • China, Global
From
  • 5 Results (Page 1 of 1)
Loading Indicator

Carglumic acid is a drug used to treat endocrine and metabolic disorders. It is a synthetic form of N-carbamoyl-L-glutamate, an intermediate in the urea cycle. Carglumic acid is used to treat N-acetylglutamate synthase (NAGS) deficiency, an inherited disorder that can cause ammonia to accumulate in the blood. It is also used to treat hyperammonemia, a condition in which the body has too much ammonia in the blood. Carglumic acid works by helping the body break down ammonia and other nitrogen-containing compounds. Carglumic acid is available in tablet and powder form. It is usually taken once or twice a day, depending on the condition being treated. Common side effects include nausea, vomiting, and diarrhea. The carglumic acid market is a niche market, with few companies offering the drug. Companies in the market include Orphan Europe, Orphan Technologies, and Orphan Canada. Show Less Read more